<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formoterol pMDI with budesonide pMDI and budesonide/formoterol DPI in asthma"</p><p></p><p>International Journal of Clinical Practice 2007;61(11):1874-1883.</p><p>Published online Jan 2007</p><p>PMCID:PMC2228375.</p><p>© 2007 The Authors Journal compilation © 2007 Blackwell Publishing Ltd</p> DPI, dry-powder inhaler; E, enrolment; FEV, forced expiratory volume in 1 s; pMDI, pressurised metered-dose inhaler; R, randomisation; W, wee
The use of a combination of the inhaled glucocorticosteroid budesonide and beta2-selective long-acti...
BACKGROUND AND OBJECTIVE: Mixed inhaler device use for asthma is associated with worse inhaler techn...
<p><b>Copyright information:</b></p><p>Taken from "Effect of budesonide/formoterol maintenance and r...
<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formot...
<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formot...
BACKGROUND: Previous single-dose crossover studies have established therapeutic equivalence of formo...
Aim: To demonstrate the non-inferiority of extrafine beclomethasone/formoterol Fumarate (BDP/FF) dry...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol/fluticasone stable-dose treatment comp...
Aims: To demonstrate the noninferiority of extrafine beclomethasone/formoterol fumarate (BDP/FF) dry...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
SummaryRationaleTo assess equivalence of twice daily (bid) budesonide/formoterol (BUD/FM) 160/4.5 μg...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
In 3 open-label studies, the systemic bioavailability of budesonide and formoterol administered via ...
The present study was designed to compare the fixed combination of beclomethasone and formoterol in ...
The use of a combination of the inhaled glucocorticosteroid budesonide and beta2-selective long-acti...
BACKGROUND AND OBJECTIVE: Mixed inhaler device use for asthma is associated with worse inhaler techn...
<p><b>Copyright information:</b></p><p>Taken from "Effect of budesonide/formoterol maintenance and r...
<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formot...
<p><b>Copyright information:</b></p><p>Taken from "Therapeutic comparison of a new budesonide/formot...
BACKGROUND: Previous single-dose crossover studies have established therapeutic equivalence of formo...
Aim: To demonstrate the non-inferiority of extrafine beclomethasone/formoterol Fumarate (BDP/FF) dry...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol/fluticasone stable-dose treatment comp...
Aims: To demonstrate the noninferiority of extrafine beclomethasone/formoterol fumarate (BDP/FF) dry...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
SummaryRationaleTo assess equivalence of twice daily (bid) budesonide/formoterol (BUD/FM) 160/4.5 μg...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
<p><b>Copyright information:</b></p><p>Taken from "Salmeterol plus fluticasone propionate versus flu...
In 3 open-label studies, the systemic bioavailability of budesonide and formoterol administered via ...
The present study was designed to compare the fixed combination of beclomethasone and formoterol in ...
The use of a combination of the inhaled glucocorticosteroid budesonide and beta2-selective long-acti...
BACKGROUND AND OBJECTIVE: Mixed inhaler device use for asthma is associated with worse inhaler techn...
<p><b>Copyright information:</b></p><p>Taken from "Effect of budesonide/formoterol maintenance and r...